semaglutide and breast cancer The Impact Safety of GLP‐1 Agents and Ozempic and similar weight-loss drugs

It has lowered my A1C levels

[DOI] [PubMed] [Google Scholar] 154.De Jonghe B.C., Holland R.A., Olivos D.R., Rupprecht L.E., Kanoski S.E., Hayes M.R

N Engl J Med 373(1):1122 Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I et al (2021) Once-weekly semaglutide in adults with overweight or obesity

doi: 10.1097/MCG.0000000000001556

The journey from clinical trials to market approval is rigorous, but the promising results from retatrutide have undoubtedly generated significant anticipation

Studies such as the SUSTAIN and STEP trials have demonstrated their benefits in both glycemic control and weight reduction, positioning GLP-1 agonists as cornerstones in the treatment of metabolic disorders